Covid-19: South Africa pauses use of Oxford vaccine after study casts doubt on efficacy against variant
Elisabeth Mahase
Abstract
Covid-19: South Africa pauses use of Oxford vaccine after study casts doubt on efficacy against variant Elisabeth MahaseRollout of the Oxford-AstraZeneca covid-19 vaccine in South Africa has been paused after a study in 2000 healthy and young volunteers reported that it did not protect against mild and moderate disease caused by the new variant (501Y.V2) that emerged there.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyFamily medicineDiseaseInfectious disease (medical specialty)PathologyOutbreakSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyImmune responses and vaccinations